Effect of Melatonin on Cardiometabolic Risk- FULL
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT02681887
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose basic science
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT02681887
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT02681887. Randomized; double masking; primary purpose basic science. Start 2016-09 (actual); primary completion 2021-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Melatonin on Cardiometabolic Risk- FULL
- Condition
- Obesity
- Condition
- Prediabetic State
- Intervention (Drug)
- Melatonin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Brigham and Women's Hospital
Record details
- Record id
cardio:ct-nct02681887- Content hash
82fb0274eab7468153f540465ae46d245d1fad98e8abf32b8abf598f94207064